FINWIRES · TerminalLIVE
FINWIRES

Biocon Receives Five Observations from US FDA After Bengaluru, India, Unit Inspection

By

Biocon (NSE:BIOCON, BOM:532523) has received five observations from the US Food and Drug Administration (US FDA) after the pre-license inspection at Biocon's biosimilars site in Bengaluru, India, according to a Thursday filing to the Indian stock exchanges.

The US FDA inspected the unit between April 20 and April 29 and covered three biologics manufacturing units, five quality testing laboratories, and two warehouses.

At the conclusion of the inspection, the U.S. FDA issued a Form 483 with five observations, which the company said are procedural in nature and do not pertain to data integrity or quality oversight.

There were no repeat observations noted, Biocon said.

The company's shares were down over 1% in recent trade.

Related Articles

Asia

Joinn Laboratories' Profit Surges 480% in Q1

Joinn Laboratories (HKG:6127, SHA:603127) posted net profit attributable to shareholders of 238.4 million yuan for the first quarter, up 480% from 41.1 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.Hong Kong-listed shares of the drug research firm were down over 6% in Thursday's late-morning trade.Earnings per share came in at 0.32 yuan, up from 0.05 yuan a year earlier.Revenue increased 10% to 316.1 million yuan from 287.3 million yuan in the prior-year period.

HKG:6127SHA:603127
Asia

Ganfeng Lithium Turns to Q1 Profit as Revenue Jumps 144%

Ganfeng Lithium (SHE:002460, HKG:1772) posted first-quarter attributable net profit of 1.84 billion yuan, compared with loss of 355.8 million yuan the previous year.Earnings per share stood at 0.88 yuan, versus loss per share of 0.18 yuan last year, according to a Thursday filing with the Shenzhen bourse.Operating revenue jumped 144% year over year to 9.20 billion yuan from 3.77 billion yuan.Shares of the lithium miner were up 2% in recent trade on the Shenzhen bourse and 1% on the Hong Kong bourse.

HKG:1772SHE:002460
Asia

Yihai Kerry Arawana Q1 Profit Up 51%, Revenue Rises 11%

Yihai Kerry Arawana (SHE:300999) posted first-quarter attributable net profit of 1.48 billion yuan, up 51% from 981.4 million yuan the previous year.Earnings per share rose to 0.27 yuan from 0.18 yuan, according to a Thursday filing with the Shenzhen bourse.Operating revenue climbed 11% year over year to 65.5 billion yuan from 59.1 billion yuan.Shares of the food products company were up 2% in recent trade.

SHE:300999